Philharmonic Orchestra film special tribute concert for the Oxford vaccine team

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Reiné J. et al, (2026), Comput Biol Chem, 122

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Hysa A. et al, (2026), PLoS Med, 23

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Thorn N. et al, (2026), Lancet Infect Dis

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Noronha IH. et al, (2026), J Infect Dis

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Jones E. et al, (2026), J Immunol, 215

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Muriuki JM. et al, (2026), Nat Commun

Relationship between antibody avidity, Fc-mediated functional activity and longevity of malaria vaccine responses in clinical trials

Horton JL. et al, (2026), Frontiers in Immunology, 17

Securing the future of immunisation: ESCMID's vision.

Ramasamy MN. et al, (2026), Clin Microbiol Infect, 32, 516 - 518

Maternal views on RSV vaccination in the UK's second season.

O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2026), PLoS Negl Trop Dis, 20

Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.

Yusuf S. et al, (2026), Lancet Infect Dis, 26, e259 - e267

Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 494 - 513

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Zhang Y. et al, (2026), EClinicalMedicine, 94

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 379 - 434

Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules

Kelly E., (2026)

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Weight CM. et al, (2026), J Infect Dis

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Turan G. et al, (2026), Vaccines (Basel), 14

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Tembo G. et al, (2026), Vaccine, 75

Search results

Showing results for